Third Rock Ventures III L.P. 13D and 13G filings for Relay Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:52 pm Sale | 2021-12-31 | 13G | Relay Therapeutics, Inc. RLAY | Third Rock Ventures III L.P. | 362,619 0.300% | -10,188,496 (-96.56%) | Filing |
| 2021-02-16 4:12 pm Purchase | 2020-12-31 | 13G | Relay Therapeutics, Inc. RLAY | Third Rock Ventures III L.P. | 10,551,115 11.700% | 10,551,115 (New Position) | Filing |